{"title":"10结论与建议","authors":"","doi":"10.1177/1473669119893186","DOIUrl":null,"url":null,"abstract":"There exists a variety of methods that are currently under development, and/or have been suggested, for emergency dosimetry following acute exposure to radiation after a radiological incident. The main methods can be classified as biodosimetry and physical dosimetry and can be performed on biological materials (primarily blood), physical (nonbiological) materials, or materials that are biologically derived (teeth, bone, nails). In addition, these methods can be supplemented by neutron activation measurements (if a neutron dose is suspected) and/or bioassays (if internal contamination is suspected). Radiation field mapping and “time and motion” studies are also useful in many circumstances. Choice of method depends on the number of affected individuals, the type of radiation exposure, and whether or not the individual may have suffered internal radiological contamination as well as external irradiation. (It can be assumed that all affected individuals will have been externally exposed.) The choice of method also depends on the goal of the measurement. If the goal is rapid screening to determine approximately the level of individual exposure, then the methods selected may or may not be the same as those methods chosen for more detailed follow-up. The former methods might be used for triage purposes, whereas the latter may be used to assist medical practitioners in determining the most appropriate interventional medical therapy. A review and analysis of the various biological and physical dosimetry methods reveals a range of maturity levels for the various techniques. Some are of such maturity as to allow immediate application in the event of a largescale exposure. Primarily these are biodosimetry methods, for example, dicentric chromosome assay (DCA) and cytokinesis-block micronucleus (CBMN) assay. In contrast, many of the physical dosimetry methods are still under development. Based on laboratory intercomparisons, optically stimulated luminescence (OSL) of electronic components is possibly the closest to real-world application. Other methods [e.g., thermoluminescence (TL)] and other target materials (e.g., smartphone glass) are still under experimental laboratory testing. Electron paramagnetic resonance (EPR) of biologically derived material (e.g., teeth) is well developed for in-vitro analysis, but not yet for in-vivo analysis. Electron paramagnetic resonance analysis of finger and toe nails is not yet ready for widespread application, despite some efforts to date in small-scale accidents. None of the bioor physical dosimetry methods by themselves are able to distinguish between internal and external exposure. Combinations of methods might be able to indicate that an internal dose component is present, but confirmation would be necessary with bioassays. Similarly, the above techniques are not yet able to distinguish neutron dose from photon dose, and in addition several of the methods have low sensitivity to neutron exposure. Thus, when neutron exposure is suspected and neutron-gamma distinction is required, the only currently available technique is neutron activation analysis in combination with one of the above methods. The emphasis of this Report has been on dosimetry during the initial phase following acute radiation exposure. As a result, the focus has been on dosimetry for deterministic effects and the measured quantity of interest is absorbed dose. It is necessary to distinguish between the quantity measured by physical dosimetry methods and that measured by biological methods. If calibration of the dosimeters used in the measurements is with penetrating, energetic photons, and if the individuals are exposed also to penetrating photons during the radiological incident, then RBE ~1 and there is no difference in the quantity measured with the 2 types of dosimetry. If one of these conditions is not met, however, the quantities measured must be considered different, depending on the value of the RBE. Knowledge of the RBE thus becomes important. The second important distinction between biodosimetry and physical dosimetry is that the former examines dose to the person, whereas the latter examines dose to some object close to (e.g., phone) or part of (e.g., teeth) the person. Differences in the dose evaluated using these 2 methods should be expected, even if the RBE value is ~1. Nevertheless, for triage measurements at least, the distinction between the quantities and values measured with physical and biodosimetry methods should not be weighed during triage consideration and may be ignored. Furthermore, the absorbed dose (in Gy) should be the quoted value and the quantity of interest. Calculations and estimates of the RBE and radiological and organ weighting factors (for effective dose estimates) may follow only if warranted for medical management and may be considered in follow-up measurements and calculations. 893186 CRUXXX10.1177/1473669119893186Journal of the ICRU XX(X)Conclusions and Recommendations research-article2020","PeriodicalId":91344,"journal":{"name":"Journal of the ICRU","volume":"17 1","pages":"124 - 128"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"10 Conclusions and Recommendations\",\"authors\":\"\",\"doi\":\"10.1177/1473669119893186\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"There exists a variety of methods that are currently under development, and/or have been suggested, for emergency dosimetry following acute exposure to radiation after a radiological incident. The main methods can be classified as biodosimetry and physical dosimetry and can be performed on biological materials (primarily blood), physical (nonbiological) materials, or materials that are biologically derived (teeth, bone, nails). In addition, these methods can be supplemented by neutron activation measurements (if a neutron dose is suspected) and/or bioassays (if internal contamination is suspected). Radiation field mapping and “time and motion” studies are also useful in many circumstances. Choice of method depends on the number of affected individuals, the type of radiation exposure, and whether or not the individual may have suffered internal radiological contamination as well as external irradiation. (It can be assumed that all affected individuals will have been externally exposed.) The choice of method also depends on the goal of the measurement. If the goal is rapid screening to determine approximately the level of individual exposure, then the methods selected may or may not be the same as those methods chosen for more detailed follow-up. The former methods might be used for triage purposes, whereas the latter may be used to assist medical practitioners in determining the most appropriate interventional medical therapy. A review and analysis of the various biological and physical dosimetry methods reveals a range of maturity levels for the various techniques. Some are of such maturity as to allow immediate application in the event of a largescale exposure. Primarily these are biodosimetry methods, for example, dicentric chromosome assay (DCA) and cytokinesis-block micronucleus (CBMN) assay. In contrast, many of the physical dosimetry methods are still under development. Based on laboratory intercomparisons, optically stimulated luminescence (OSL) of electronic components is possibly the closest to real-world application. Other methods [e.g., thermoluminescence (TL)] and other target materials (e.g., smartphone glass) are still under experimental laboratory testing. Electron paramagnetic resonance (EPR) of biologically derived material (e.g., teeth) is well developed for in-vitro analysis, but not yet for in-vivo analysis. Electron paramagnetic resonance analysis of finger and toe nails is not yet ready for widespread application, despite some efforts to date in small-scale accidents. None of the bioor physical dosimetry methods by themselves are able to distinguish between internal and external exposure. Combinations of methods might be able to indicate that an internal dose component is present, but confirmation would be necessary with bioassays. Similarly, the above techniques are not yet able to distinguish neutron dose from photon dose, and in addition several of the methods have low sensitivity to neutron exposure. Thus, when neutron exposure is suspected and neutron-gamma distinction is required, the only currently available technique is neutron activation analysis in combination with one of the above methods. The emphasis of this Report has been on dosimetry during the initial phase following acute radiation exposure. As a result, the focus has been on dosimetry for deterministic effects and the measured quantity of interest is absorbed dose. It is necessary to distinguish between the quantity measured by physical dosimetry methods and that measured by biological methods. If calibration of the dosimeters used in the measurements is with penetrating, energetic photons, and if the individuals are exposed also to penetrating photons during the radiological incident, then RBE ~1 and there is no difference in the quantity measured with the 2 types of dosimetry. If one of these conditions is not met, however, the quantities measured must be considered different, depending on the value of the RBE. Knowledge of the RBE thus becomes important. The second important distinction between biodosimetry and physical dosimetry is that the former examines dose to the person, whereas the latter examines dose to some object close to (e.g., phone) or part of (e.g., teeth) the person. Differences in the dose evaluated using these 2 methods should be expected, even if the RBE value is ~1. Nevertheless, for triage measurements at least, the distinction between the quantities and values measured with physical and biodosimetry methods should not be weighed during triage consideration and may be ignored. Furthermore, the absorbed dose (in Gy) should be the quoted value and the quantity of interest. Calculations and estimates of the RBE and radiological and organ weighting factors (for effective dose estimates) may follow only if warranted for medical management and may be considered in follow-up measurements and calculations. 893186 CRUXXX10.1177/1473669119893186Journal of the ICRU XX(X)Conclusions and Recommendations research-article2020\",\"PeriodicalId\":91344,\"journal\":{\"name\":\"Journal of the ICRU\",\"volume\":\"17 1\",\"pages\":\"124 - 128\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the ICRU\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1473669119893186\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the ICRU","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1473669119893186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目前正在开发和(或)已提出各种方法,用于放射性事件后急性辐射照射后的紧急剂量测定。主要方法可分为生物剂量测定法和物理剂量测定法,可对生物材料(主要是血液)、物理(非生物)材料或生物衍生材料(牙齿、骨骼、指甲)进行测定。此外,这些方法可以通过中子活化测量(如果怀疑有中子剂量)和/或生物测定(如果怀疑有内部污染)来补充。辐射场测绘和“时间和运动”研究在许多情况下也很有用。方法的选择取决于受影响个人的人数、辐射暴露的类型,以及个人是否可能受到内部辐射污染和外部辐射。(可以假设所有受影响的人都曾在外部接触过。)方法的选择也取决于测量的目标。如果目标是快速筛选以确定个人暴露的大致水平,那么所选择的方法可能与为更详细的随访所选择的方法相同,也可能不同。前一种方法可用于分诊,而后一种方法可用于协助医生确定最合适的介入性医学治疗。对各种生物和物理剂量测定方法的回顾和分析揭示了各种技术的成熟度范围。有些是如此成熟,允许在大规模暴露的情况下立即应用。这些主要是生物剂量测定方法,例如,双中心染色体测定(DCA)和细胞分裂阻断微核(CBMN)测定。相比之下,许多物理剂量测定方法仍在发展中。基于实验室的相互比较,电子元件的光激发发光(OSL)可能是最接近实际应用的。其他方法[如热释光(TL)]和其他目标材料(如智能手机玻璃)仍处于实验室试验阶段。生物来源材料(如牙齿)的电子顺磁共振(EPR)在体外分析方面发展得很好,但在体内分析方面还没有发展。电子顺磁共振分析手指和脚趾指甲还没有准备好广泛应用,尽管一些小规模事故的努力。没有一种生物或物理剂量法本身能够区分内部和外部照射。多种方法的组合可能表明存在内剂量成分,但需要用生物测定法进行确认。同样,上述技术还不能区分中子剂量和光子剂量,此外,有几种方法对中子照射的灵敏度较低。因此,当怀疑中子暴露并需要中子-伽马区分时,目前唯一可用的技术是中子活化分析与上述方法之一相结合。本报告的重点是急性辐射照射后初始阶段的剂量测定。因此,重点一直放在剂量学上以确定效应,而感兴趣的测量量是吸收剂量。有必要区分用物理剂量法测量的量和用生物方法测量的量。如果测量中使用的剂量计的校准是使用穿透性高能光子,并且如果个体在辐射事件中也暴露于穿透性光子,则RBE ~1和两种剂量法测量的量没有差异。但是,如果不满足其中一个条件,则根据RBE的值,必须认为测量的量是不同的。因此,了解RBE变得很重要。生物剂量学和物理剂量学之间的第二个重要区别是,前者检测的是对人体的剂量,而后者检测的是对人体附近物体(如电话)或身体部分(如牙齿)的剂量。即使RBE值为~1,使用这两种方法评估的剂量也会有差异。然而,至少对于分诊测量,在分诊考虑时不应权衡物理和生物剂量法测量的量和值之间的区别,可以忽略。此外,吸收剂量(Gy)应是报价和感兴趣的量。只有在医疗管理需要的情况下,才能计算和估计RBE以及放射学和器官加权因子(用于有效剂量估计),并在后续测量和计算中予以考虑。893186 CRUXXX10。 1177/1473669119893186 ICRU期刊XX(X) conclusion and Recommendations research-article2020
There exists a variety of methods that are currently under development, and/or have been suggested, for emergency dosimetry following acute exposure to radiation after a radiological incident. The main methods can be classified as biodosimetry and physical dosimetry and can be performed on biological materials (primarily blood), physical (nonbiological) materials, or materials that are biologically derived (teeth, bone, nails). In addition, these methods can be supplemented by neutron activation measurements (if a neutron dose is suspected) and/or bioassays (if internal contamination is suspected). Radiation field mapping and “time and motion” studies are also useful in many circumstances. Choice of method depends on the number of affected individuals, the type of radiation exposure, and whether or not the individual may have suffered internal radiological contamination as well as external irradiation. (It can be assumed that all affected individuals will have been externally exposed.) The choice of method also depends on the goal of the measurement. If the goal is rapid screening to determine approximately the level of individual exposure, then the methods selected may or may not be the same as those methods chosen for more detailed follow-up. The former methods might be used for triage purposes, whereas the latter may be used to assist medical practitioners in determining the most appropriate interventional medical therapy. A review and analysis of the various biological and physical dosimetry methods reveals a range of maturity levels for the various techniques. Some are of such maturity as to allow immediate application in the event of a largescale exposure. Primarily these are biodosimetry methods, for example, dicentric chromosome assay (DCA) and cytokinesis-block micronucleus (CBMN) assay. In contrast, many of the physical dosimetry methods are still under development. Based on laboratory intercomparisons, optically stimulated luminescence (OSL) of electronic components is possibly the closest to real-world application. Other methods [e.g., thermoluminescence (TL)] and other target materials (e.g., smartphone glass) are still under experimental laboratory testing. Electron paramagnetic resonance (EPR) of biologically derived material (e.g., teeth) is well developed for in-vitro analysis, but not yet for in-vivo analysis. Electron paramagnetic resonance analysis of finger and toe nails is not yet ready for widespread application, despite some efforts to date in small-scale accidents. None of the bioor physical dosimetry methods by themselves are able to distinguish between internal and external exposure. Combinations of methods might be able to indicate that an internal dose component is present, but confirmation would be necessary with bioassays. Similarly, the above techniques are not yet able to distinguish neutron dose from photon dose, and in addition several of the methods have low sensitivity to neutron exposure. Thus, when neutron exposure is suspected and neutron-gamma distinction is required, the only currently available technique is neutron activation analysis in combination with one of the above methods. The emphasis of this Report has been on dosimetry during the initial phase following acute radiation exposure. As a result, the focus has been on dosimetry for deterministic effects and the measured quantity of interest is absorbed dose. It is necessary to distinguish between the quantity measured by physical dosimetry methods and that measured by biological methods. If calibration of the dosimeters used in the measurements is with penetrating, energetic photons, and if the individuals are exposed also to penetrating photons during the radiological incident, then RBE ~1 and there is no difference in the quantity measured with the 2 types of dosimetry. If one of these conditions is not met, however, the quantities measured must be considered different, depending on the value of the RBE. Knowledge of the RBE thus becomes important. The second important distinction between biodosimetry and physical dosimetry is that the former examines dose to the person, whereas the latter examines dose to some object close to (e.g., phone) or part of (e.g., teeth) the person. Differences in the dose evaluated using these 2 methods should be expected, even if the RBE value is ~1. Nevertheless, for triage measurements at least, the distinction between the quantities and values measured with physical and biodosimetry methods should not be weighed during triage consideration and may be ignored. Furthermore, the absorbed dose (in Gy) should be the quoted value and the quantity of interest. Calculations and estimates of the RBE and radiological and organ weighting factors (for effective dose estimates) may follow only if warranted for medical management and may be considered in follow-up measurements and calculations. 893186 CRUXXX10.1177/1473669119893186Journal of the ICRU XX(X)Conclusions and Recommendations research-article2020